What is the Non-Invasive Prenatal Test (NIPT)?

NIPT (Non-Invasive Prenatal Test) is a genetic screening test that a pregnant woman can perform from the 10th week of pregnancy. The NIPT test can determine if your baby has trisomy 21, trisomy 18, or trisomy 13. The term “trisomy” is used to describe the presence of an extra chromosome – or three instead of the usual pair.

For example, trisomy 21 (Down syndrome) occurs when a baby is born with three children on chromosome 21. NIPT also provides additional testing options for certain other rare trisomies, sex chromosome aneuploids (an abnormal number of sex chromosomes) and changes in the number of children, which include deletion syndromes (a loss of part of a chromosome), duplication syndromes (an addition of part of a chromosome), and certain inherited genetic disorders (a disorder caused by a gene mutation that is transmitted from parent to child). If you want to know, the NIPT test can also provide information about the sex of the fetus.

What are the benefits of NIPT testing?

NIPT testing is ideal for people who want to obtain information about the health of the fetus in a non-invasive way or to detect possible genetic abnormalities early in its development. The benefits of non-invasive testing include:
Elimination of the risk of miscarriage after consultation
Detection of chromosomal disorders on 23 pairs of chromosomes
Eligible health insurance – in case of positive screening tests
Avoid an invasive diagnostic procedure
Accurate diagnosis of Down syndrome cases
Obtaining accurate information on the health of the fetus
Early detection of ultrasound abnormalities (any possible monogenic disorders)
Screening options for 96 different genetic conditions

Types of NIPT tests available


for Trisomies 21, 18, 13, 9, 16, 22 + 84 Microdeletion/Duplication Syndromes + Sex Chromosome Aneuploidy + with/whitout Sex Information + Incidental findings*

This type of testing offers a clear and early conclusion regarding sex chromosomal aneuploidies or deletion/duplication syndromes.

Explore the complete list of studied disorders

Free worldwide shipping and sample collection
Results delivery duration 10 days



for Non-invasive dominant single gene fetal screening

This test provides screening for 27 diseases, including skeletal, cardiac, and syndromic disorders caused by (2038) single-gene variants in 18 genes. The conditions examined include those associated with the average paternal age (men over the age of 40).

Explore the complete list of studied disorders

Free worldwide shipping and sample collection
Results delivery duration 16 days


How does NIPT work?

During pregnancy, DNA from the mother and placenta circulates in the mother’s blood. NIPT works by taking a small sample of maternal blood of about 10ml and evaluating the genetic information in this sample. The assessment is done by applying whole-genome sequencing and advanced bioinformatics analysis to determine the risk of specific genetic disorders.

NIPT is a screening test, which means that it does not test with 100% accuracy and, therefore should not be used as the sole basis for diagnosis or other pregnancy management decisions.